2019/23864-7/Fundação de Amparo à Pesquisa do Estado de São Paulo[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	2
2024	0

Page 1

ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells.

de Almeida BO, de Almeida LC, Costa-Lotufo LV, Machado-Neto JA. de Almeida BO, et al. Cell Biol Int. 2022 Sep;46(9):1433-1446. doi: 10.1002/cbin.11844. Epub 2022 Jul 16. Cell Biol Int. 2022. PMID: 35842770

NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells.

Lipreri da Silva JC, Carvalho MFL, de Miranda LBL, de Almeida BO, Lima K, Machado-Neto JA. Lipreri da Silva JC, et al. Invest New Drugs. 2022 Aug;40(4):728-737. doi: 10.1007/s10637-022-01249-z. Epub 2022 Apr 28. Invest New Drugs. 2022. PMID: 35477813

Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.

Lipreri da Silva JC, Coelho-Silva JL, Lima K, Vicari HP, Lazarini M, Costa-Lotufo LV, Traina F, Machado-Neto JA. Lipreri da Silva JC, et al. Cell Oncol (Dordr). 2021 Oct;44(5):1105-1117. doi: 10.1007/s13402-021-00621-0. Epub 2021 Jul 1. Cell Oncol (Dordr). 2021. PMID: 34196912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year